These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20674150)

  • 21. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome.
    Ficarra V; Novara G; Iafrate M; Cappellaro L; Bratti E; Zattoni F; Artibani W
    Eur Urol; 2007 Mar; 51(3):722-9; discussion 729-31. PubMed ID: 16904819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic role of tumour multifocality in renal cell carcinoma.
    Siracusano S; Novara G; Antonelli A; Artibani W; Bertini R; Carini M; Carmignani G; Ciciliato S; Cunico SC; Lampropoulou N; Longo N; Martorana G; Minervini A; Mirone V; Simeone C; Simonato A; Valotto C; Zattoni F; Ficarra V;
    BJU Int; 2012 Dec; 110(11 Pt B):E443-8. PubMed ID: 22502873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-institutional Survival Analysis of Incidental Pathologic T3a Upstaging in Clinical T1 Renal Cell Carcinoma Following Partial Nephrectomy.
    Russell CM; Lebastchi AH; Chipollini J; Niemann A; Mehra R; Morgan TM; Miller DC; Palapattu GS; Hafez KS; Sexton WJ; Spiess PE; Weizer AZ
    Urology; 2018 Jul; 117():95-100. PubMed ID: 29678662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion.
    Han KR; Bui MH; Pantuck AJ; Freitas DG; Leibovich BC; Dorey FJ; Zisman A; Janzen NK; Mukouyama H; Figlin RA; Belldegrun AS
    J Urol; 2003 Mar; 169(3):899-903; discussion 903-4. PubMed ID: 12576809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.
    Bedke J; Buse S; Pritsch M; Macher-Goeppinger S; Schirmacher P; Haferkamp A; Hohenfellner M
    BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma.
    Sugiyama Y; Yatsuda J; Murakami Y; Ito N; Yamasaki T; Mikami Y; Ogawa O; Kamba T
    Jpn J Clin Oncol; 2019 May; 49(5):465-472. PubMed ID: 30793163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic radical nephrectomy for large renal masses: critical assessment of perioperative and oncologic outcomes of stage T2a and T2b tumors.
    Pierorazio PM; Hyams ES; Lin BM; Mullins JK; Allaf ME
    Urology; 2012 Mar; 79(3):570-5. PubMed ID: 22386399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version?
    Waalkes S; Becker F; Schrader AJ; Janssen M; Wegener G; Merseburger AS; Schrader M; Hofmann R; Stöckle M; Kuczyk MA
    Eur Urol; 2011 Feb; 59(2):258-63. PubMed ID: 21030143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?
    Thompson RH; Leibovich BC; Cheville JC; Lohse CM; Frank I; Kwon ED; Zincke H; Blute ML
    J Urol; 2005 Mar; 173(3):918-21. PubMed ID: 15711327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
    Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
    BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Risk factors for recurrence in pT3aN0M0 renal cell carcinoma according to 2009 TNM classification].
    Utsunomiya N; Kono Y; Matsumoto K; Sumiyoshi T; Masuda N; Shiraishi Y; Negoro H; Tsunemori H; Sugino Y; Okubo K; Okada T; Segawa T; Muguruma K; Kawakita M
    Hinyokika Kiyo; 2014 Jan; 60(1):1-5. PubMed ID: 24594765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors.
    Salama ME; Guru K; Stricker H; Peterson E; Peabody J; Menon M; Amin MB; De Peralta-Venturina M
    J Urol; 2005 May; 173(5):1492-5. PubMed ID: 15821466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncological outcomes of patients with incidental pathological T3a stage small renal cell carcinoma after partial nephrectomy.
    Lee C; You D; Yoo S; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1651-7. PubMed ID: 27193144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    Cancer; 2007 Jun; 109(12):2439-44. PubMed ID: 17487856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
    Carini M; Minervini A; Lapini A; Masieri L; Serni S
    J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
    Capitanio U; Suardi N; Matloob R; Roscigno M; Abdollah F; Di Trapani E; Moschini M; Gallina A; Salonia A; Briganti A; Montorsi F; Bertini R
    BJU Int; 2014 Aug; 114(2):210-5. PubMed ID: 24854206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma.
    Bertini R; Roscigno M; Freschi M; Strada E; Angiolilli D; Petralia G; Matloob R; Sozzi F; Capitanio U; Da Pozzo LF; Colombo R; Guazzoni G; Cremonini A; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):358-65. PubMed ID: 21640483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal cell carcinoma. 2002 TNM classification is still adequate?
    Fandella A; Borghesi M; Bertaccini A
    Arch Ital Urol Androl; 2009 Mar; 81(1):51-5. PubMed ID: 19499760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
    Klatte T; Patard JJ; Goel RH; Kleid MD; Guille F; Lobel B; Abbou CC; De La Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Artibani W; Prayer-Galetti T; Allhoff EP; Schips L; Zigeuner R; Figlin RA; Kabbinavar FF; Pantuck AJ; Belldegrun AS; Lam JS
    J Urol; 2007 Jul; 178(1):35-40; discussion 40. PubMed ID: 17521678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.